Scholarlink

<p>Inflammatory bowel disease (IBD) is a chronic intestinal disorder characterized by intestinal barrier dysfunction and immune dysregulation, with limited safe and effective therapeutic options available. Owing to their biocompatibility and bioactivity, plant exosome-like nanoparticles (PELNs) have emerged as promising natural nanotherapeutics. In this study, exosome-like nanovesicles from Chinese bayberry (<i>Myrica rubra</i>) were isolated, characterized, and termed BELNs to investigate their therapeutic potential against IBD. Purified BELNs exhibited a typical bilayer membrane structure with a 100–300 nm size. Lipidomic, proteomic, and miRNA sequencing analyses revealed that BELNs contain bioactive components, including diacylglycerols, sphingomyelin, specific proteins, miRNAs, and polyphenols like cyanidin-3-O-glucoside. In vitro experiments demonstrated that BELNs were internalized by RAW 264.7 macrophages via galactose-mediated endocytosis, reducing LPS-induced proinflammatory cytokines (TNF-α and IL-1β) and increasing anti-inflammatory IL-10. In vivo, orally administered BELNs accumulated predominantly in the murine gastrointestinal tract. In a DSS-induced IBD model, BELNs alleviated disease symptoms, preserved intestinal tissue integrity, and enhanced barrier function by upregulating tight junction protein ZO-1 and mucin MUC2. Additionally, BELNs remodeled the gut microbiota by decreasing <i>Escherichia-Shigella</i> and enriching beneficial short-chain fatty acid-producing bacteria. These findings highlight BELNs’ potential as safe and effective nanotherapeutics for treating ulcerative colitis through immunoregulation, barrier repair, and microbiota modulation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chinese bayberry exosome-like nanoparticles attenuate DSS-induced colitis via immunomodulation, barrier restoration, and microbiota remodeling

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月14日

查看全文
  • Mengting Wang,
  • Zixin Shao,
  • Zhijian Ke,
  • Haiguang Mao,
  • Lili Qi,
  • Jinbo Wang

摘要

Inflammatory bowel disease (IBD) is a chronic intestinal disorder characterized by intestinal barrier dysfunction and immune dysregulation, with limited safe and effective therapeutic options available. Owing to their biocompatibility and bioactivity, plant exosome-like nanoparticles (PELNs) have emerged as promising natural nanotherapeutics. In this study, exosome-like nanovesicles from Chinese bayberry (Myrica rubra) were isolated, characterized, and termed BELNs to investigate their therapeutic potential against IBD. Purified BELNs exhibited a typical bilayer membrane structure with a 100–300 nm size. Lipidomic, proteomic, and miRNA sequencing analyses revealed that BELNs contain bioactive components, including diacylglycerols, sphingomyelin, specific proteins, miRNAs, and polyphenols like cyanidin-3-O-glucoside. In vitro experiments demonstrated that BELNs were internalized by RAW 264.7 macrophages via galactose-mediated endocytosis, reducing LPS-induced proinflammatory cytokines (TNF-α and IL-1β) and increasing anti-inflammatory IL-10. In vivo, orally administered BELNs accumulated predominantly in the murine gastrointestinal tract. In a DSS-induced IBD model, BELNs alleviated disease symptoms, preserved intestinal tissue integrity, and enhanced barrier function by upregulating tight junction protein ZO-1 and mucin MUC2. Additionally, BELNs remodeled the gut microbiota by decreasing Escherichia-Shigella and enriching beneficial short-chain fatty acid-producing bacteria. These findings highlight BELNs’ potential as safe and effective nanotherapeutics for treating ulcerative colitis through immunoregulation, barrier repair, and microbiota modulation.